Definium Therapeutics Inc. Company Profile
NASDAQ: DFTXHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Definium Therapeutics at a glance
Definium Therapeutics Inc. (NASDAQ: DFTX) is a Medicinal Chemicals and Botanical Products company in the Health Care sector headquartered in New York, NY. Definium Therapeutics is led by Mr. Robert Barrow and employs about 105 people. At a market capitalization of $4.79 billion, it is considered a mid-cap company.
Its SEC Central Index Key (CIK) is 0001813814, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Definium Therapeutics do?
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Definium Therapeutics Inc.
- Ticker
- NASDAQ: DFTX
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Robert Barrow
- Employees
- 105
- Headquarters
- One World Trade Center, New York, NY, United States
- Phone
- 212 220 6633
- Website
- definiumtx.com
- Market cap
- $4.79B
- SEC CIK
- 0001813814
Companies similar to Definium Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TRLVTrulieve Cannabis Corp. Subordinate Voting Shares | 10.78 | +1.22% | $2.08B | vs DFTX |
| CRONCronos Group Inc. | 3.24 | -1.37% | $1.19B | vs DFTX |
| TLRYTilray Brands Inc. | 3.72 | -1.72% | $549.01M | vs DFTX |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 5.13 | -0.58% | $483.46M | vs DFTX |
| CGCCanopy Growth Corporation | 0.8765 | -1.59% | $393.81M | vs DFTX |
| OBIOOrchestra BioMed Holdings Inc. | 5.66 | -3.08% | $340.19M | vs DFTX |
| SNDLSNDL Inc. | 1.25 | +1.63% | $307.65M | vs DFTX |
| ACBAurora Cannabis Inc. | 4.46 | -2.83% | $282.36M | vs DFTX |